Edgardo S. Santos, M.D., FACP, FASCO
@EdgardoSantosMD
Followers
876
Following
502
Statuses
717
Lung cancer specialist
Fort Lauderdale, Florida
Joined February 2022
RT @Jbauml: Excited to announce the European Commission approved our chemotherapy-free combination therapy for the first-line treatment of…
0
4
0
Dr. Fernando Dezarraga, GI oncologist from Baptist Health lecturing on the hottest topic in oncology: MRD in the adjuvant CRC at the 2024 Updates in Cancer Therapy. #UCT2024 @mecmededucation @BaptistHealthSF @OncologyInst @FLASCO_ORG @edgardo_ny @LuisRaezMD @faucollegeofmed
0
1
7
Dr. Gregory Vidal, a breast cancer expert, lecturing on the latest data in IO for patients with metastatic breast cancer. Session led by Dr. Lauren Carcas from Baptist Health South Florida at the #UCT2024. @LCarcasMD @BaptistHealthSF @mecmededucation @faucollegeofmed @edgardo_ny
0
1
6
Dr. Triparna Sen lecturing on the latest approvals and where the field for SCLC is moving now here at the 2024 UCT Symposium. @triparnasen @LuisRaezMD @mecmededucation @FLASCO_ORG @faucollegeofmed @edgardo_ny @OncologyInst #UCT2024
0
0
3
Dr. Bruna Pellini talking about targeted therapies in NSCLC after ASCO and ESMO 2024. A lot of combinations available for EGFR mutant tumors, and novel indications for HER2 alterations and ROS1 here in 2024 UCT. @BrunaPellini @OncologyInst @FLASCO_ORG @BaptistHealthSF @LuisRaezMD
0
1
5
RT @LuisRaezMD: Begining UCT#2024 in Miami with GU and GYO sessions with @PBarataMD @CParkMD dr Olawaiye @UPMC #cancer #CancerAwareness @me…
0
3
0
RT @mecmededucation: Final Countdown!⏳ December 6-7, 2024 Highlights from Leading International Congresses This is your chance to gain excl…
0
2
0
Dr. George Simon giving the updates for immunotherapy and its resistant mechanisms after 1L in advanced NSCLC at the 2024 UCT. PD-L1 0% is still an unmet need. @IASLC @OncologyInst @mecmededucation @faucollegeofmed @LuisRaezMD @FLASCO_ORG @BaptistHealthSF #UCT2024
0
0
2
Professor Pedro Barata giving the Updates in 2024 for kidney and bladder cancer in the Updates in Cancer Therapies (UCT). @OncologyInst @FLASCO_ORG @mecmededucation @ASCO @myESMO @LuisRaezMD @PBarataMD @faucollegeofmed @edgardo_ny @BaptistHealthSF
0
2
8
Dr. Alexander Olawaiye from Univ of Pittsburgh kicking off the 2024 Update in Cancer Therapy here at the Hilton Aventura. Discussing the impact of BRCA as a target. @OncologyInst @FLASCO_ORG @ASCO @LuisRaezMD @mecmededucation @faucollegeofmed @edgardo_ny
0
0
1
0
0
0
Finally, our lung cancer patients and pancreas cancer with NRG1 fusion protein (genomic alteration) have a new treatment. Zenocutuzumab. Remember to test all your patients with NSCLC using next generation sequencing (NGS), which includes DNA and RNA analyses. @IASLC @OncologyInst
0
1
2
The New Orleans Summer Cancer Meeting. Do not miss the big 20th year celebration of this extraordinary CME/CE event.
0
0
0
RT @Latinamd: #MATOS24 @StephenVLiu @LombardiCancer presents a case of HER2+ mutation PDL1+ lung cancer w multifocal progression post adjuv…
0
5
0
@lungoncdoc @christine_lovly @LuisRaezMD @marinagarassino @NaglaAKarimMD @jpmd901 @rajatthawani @drshieldsmd @chulkimMD @triparnasen @Sonampuri What a great family. Kudos MaTOS and IASLC members. Love u guys.
1
2
8
RT @lungoncdoc: Just a group of your favorite thoracic oncologists gathering in beautiful Lake Tahoe to discuss the latest in lung cancer c…
0
10
0
RT @KellyMercierPh1: Both @drshieldsmd and Dr Christine Hann reviewed the on-going studies of #ES-SCLC. Interesting that there are several…
0
8
0
RT @LuisRaezMD: Lorlatinib is the first line ALK inhibitor with this benefit @ALKpositiveINT @ALKPositiveinc #lungcancer #LCSM
0
2
0